Back to results
US 2024/0091705 A1Published application
Removal of free-unlabeled cationic and anionic solution phase radionuclides from radiopharmaceuticals using solid-phase extraction techniques
AssigneeViewpoint Molecular Targeting, Inc.
InventorsMichael K. Schultz, Mengshi Li, Edwin Sagastume
Life of this patent
Estimating the term…
Abstract
The present invention relates to a process of removing free-unlabeled radionuclides from a radiopharmaceutical prior to administering the radiopharmaceutical to the patient using size-exclusion or ion-exchange mechanisms.
Claims7
A method of removing free radionuclides from a radiopharmaceutical formulation using a process selected from the group consisting of size exclusion and ion-exchange.
Dependencies are inferred from the claim text.